Baird Financial Group, Inc.
Position in KNSA — Kiniksa Pharmaceuticals International, plc
CIK 1648711
MILWAUKEE, WI
Position in KNSA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,963,776
+$25,787 QoQ
Shares Held
30,708
-23.7% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#97
of 264 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KNSA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Baird Financial Group, Inc. holds $29,735,464 across 12 Drug Manufacturers - Specialty & Generic names. KNSA ranks #7 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
131,829 | $9,473,231 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
39,868 | $6,719,350 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
29,356 | $3,256,753 | |
| 4 | ALKS |
Alkermes plc.
|
53,267 | $2,791,190 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
65,575 | $2,273,484 | |
| 6 | VTRS |
Viatris Inc
|
130,001 | $2,064,415 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
This page
|
30,708 | $1,963,776 | |
| 8 | PAHC |
Phibro Animal Health Corp
|
10,710 | $336,293 |
All Filings in KNSA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,963,776 | 30,708 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,937,989 | 40,249 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,742,276 | 42,237 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,147,764 | 55,312 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,530,483 | 55,312 | Shares | Defined | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||